PMID- 23428667 OWN - NLM STAT- MEDLINE DCOM- 20130819 LR - 20151119 IS - 1421-9751 (Electronic) IS - 0008-6312 (Linking) VI - 124 IP - 2 DP - 2013 TI - A multimarker study of degenerative aortic valve disease: stenoinsufficiency shows more indices of bad prognosis. PG - 126-37 LID - 10.1159/000346396 [doi] AB - OBJECTIVES: It was the aim of this study to assess the pathophysiological, prognostic role of aortic regurgitation (AR) in the 'mixed pictures' of degenerative aortic valve stenoinsufficiency (ASI) by a multimarker clinical approach. METHODS: We enrolled 112 consecutive surgical PATIENTS: 19 with pure valve stenosis (PAS), 39 with mild regurgitation, 29 with severe regurgitation, and 25 controls with annulo-ectatic AR. All underwent complete echocardiography, carotid ultrasound and aortic/coronary multislice computed tomography calcium score evaluation. We determined tissue semiquantitative osteopontin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs) and circulating brain natriuretic peptide. We evaluated major adverse cardiac events and cardiovascular early, long-term mortality after bioprosthetic valve implantation. RESULTS: Tissue calcification, carotid and coronary atherosclerotic disease were prevalent in PAS versus ASI and AR patients. The multislice computed tomography calcium score (Agatston) was comparable between PAS and ASI (PAS 3,507.3 + 2,442.6; mild AR 4,270.7 + 2,213.5; severe AR 3,568.5 + 1,823.4), but much lower in AR (1,247.8 + 2,708.6). In ASI, a plasma/tissue 'profibrotic' MMP/TIMP balance prevailed, with circulating and echocardiographic indices of myocardial dysfunction. Percentages of major adverse cardiac events and early, long-term mortality were higher in ASI. CONCLUSIONS: In ASI, different, still unknown, genetic and dysplastic factors could work synergically with cardiovascular risk factors, determining a much more adverse myocardial and valve remodeling, resulting in worse clinical outcome. CI - Copyright (c) 2013 S. Karger AG, Basel. FAU - Vianello, Annamaria AU - Vianello A AD - Department of Human Morphology and Applied Biology, University of Pisa, Pisa, Italy. FAU - Perlini, Stefano AU - Perlini S FAU - Cappelli, Stefania AU - Cappelli S FAU - Palladini, Giuseppina AU - Palladini G FAU - Epistolato, Maria Carmela AU - Epistolato MC FAU - Della Latta, Daniele AU - Della Latta D FAU - Cerillo, Alfredo AU - Cerillo A FAU - Berti, Sergio AU - Berti S FAU - Chiappino, Dante AU - Chiappino D FAU - Tanganelli, Piero AU - Tanganelli P FAU - Glauber, Mattia AU - Glauber M FAU - Mazzone, Annamaria AU - Mazzone A LA - eng PT - Journal Article DEP - 20130221 PL - Switzerland TA - Cardiology JT - Cardiology JID - 1266406 RN - 0 (Biomarkers) RN - 0 (Tissue Inhibitor of Metalloproteinases) RN - 106441-73-0 (Osteopontin) RN - 114471-18-0 (Natriuretic Peptide, Brain) RN - EC 3.4.- (Metalloproteases) SB - IM MH - Aged MH - Aortic Valve Insufficiency/*mortality/pathology/surgery MH - Aortic Valve Stenosis/*mortality/pathology MH - Atherosclerosis/mortality/pathology MH - Biomarkers/*metabolism MH - Bioprosthesis/adverse effects MH - Carotid Stenosis/mortality/pathology MH - Case-Control Studies MH - Female MH - Heart Valve Prosthesis Implantation/adverse effects MH - Humans MH - Male MH - Metalloproteases/metabolism MH - Natriuretic Peptide, Brain/metabolism MH - Osteopontin/metabolism MH - Prognosis MH - Prospective Studies MH - Tissue Inhibitor of Metalloproteinases/metabolism MH - Vascular Calcification/mortality/pathology EDAT- 2013/02/23 06:00 MHDA- 2013/08/21 06:00 CRDT- 2013/02/23 06:00 PHST- 2012/05/30 00:00 [received] PHST- 2012/11/27 00:00 [accepted] PHST- 2013/02/23 06:00 [entrez] PHST- 2013/02/23 06:00 [pubmed] PHST- 2013/08/21 06:00 [medline] AID - 000346396 [pii] AID - 10.1159/000346396 [doi] PST - ppublish SO - Cardiology. 2013;124(2):126-37. doi: 10.1159/000346396. Epub 2013 Feb 21.